Navigation Links
SCD-iBIO Announces Second International Forum on Commercializing Global Green
Date:8/22/2013

WASHINGTON, Aug. 22, 2013 /PRNewswire-USNewswire/ -- SCD-iBIO, an industrial biotechnology focused group affiliated with the Society of Chemical Manufacturers and Affiliates (SOCMA), today announced that the Second International Forum on Commercializing Global Green: Markets from the Value Chain Perspective will be held November 11-13, 2013, at the Chemical Heritage Foundation (CHF) in Philadelphia, PA.

SCD-iBIO organized the forum to address the broad range of markets industrial biotechnology penetrates and discuss key issues facing the industry, such as shale gas and gas liquids. 

"The advent of shale gas and gas liquids has changed the landscape of chemical production and products," said William B. Armiger, Ph.D., Executive Director of SCD-iBIO and President of BioChemInsights, Inc. "Petroleum feedstocks (specifically naphtha) previously were used, but now natural gas liquids like ethane and propane are taking its place. Because of the feedstock change, industrial biotechnology is being asked to complement natural gas liquid-based production with products that would normally come from naphtha-based steam crackers. Attendees at our meeting will go away with a better understanding of what the future holds for partnerships between shale gas and industrial biotechnology," he said.

The three-day interactive event will include not only in-depth discussions but opportunities to network and form new professional relationships. End markets that will be highlighted include packaging, automotive, advanced biofuels and personal care, as well as intermediate markets for coatings, adhesives and sealants. The forum offers attendees an opportunity to ask questions, express opinions and widen their perspectives.

"Our forums bring together companies along the entire iBIO value chain from raw materials to commercial brands in an intimate and interactive environment where they can gain an in-depth understanding of the market forces and technological advances driving business growth," Armiger said.

About SCD-iBIO

SCD-iBO, an affiliate of SOCMA, is a company member organization that advances the commercial development of industrial biotechnology, which is the application of biology for the environmentally friendly and economically sustainable production and processing of chemicals, plastics, materials and energy. SCD-iBIO provides its members access to the latest technical knowledge in industrial biotechnology combined with the best business practices for commercial development. With industrial biotechnology rapidly emerging as a key technology for economic growth on a global-scale, SCD-iBIO supports its members' common goal of creating a sustainable chemical industry meeting the needs of the 21st century. www.SCD-iBIO.org

Contact:
Jenny Gaines
Manager, Public Relations & Media
(202) 721-4123
gainesj@socma.com


'/>"/>
SOURCE Society of Chemical Manufacturers and Affiliates
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. SOCMA Announces Launch of SCD-iBIO Group
2. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
3. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
4. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
5. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
6. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
7. WuXi PharmaTech Announces Third-Quarter 2011 Results
8. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
9. Spherix Announces Third Quarter Financial Results
10. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
11. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
Breaking Biology Technology:
(Date:6/9/2016)... 2016  Perkotek an innovation leader in attendance control systems is proud to announce ... for employers to make sure the right employees are actually signing in, and to ... ... ... ...
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):